This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,816,352 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,087.28 and a period of performance through January 2, 2025. The award is not designated as a set-aside contract.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award appears to be a delivery order issued under that broader IDC contract.
Generated 4/1/25, 3:42 PM